eSense-Lab reports major progress in R&D strengthening their position in the market

eSense-Lab reports major progress in R&D strengthening their position in the market

Medicinal cannabis and life sciences company eSense-Lab Ltd (ASX: ESE) has reported major progress in its research and development (R&D) of medical cannabis terpene blends.

The company has reported progress in its R&D activity demonstrating a

robust antioxidant activity for its medical cannabis terpene blends, manifested by a dose response of up to five per cent. Terpenes are responsible for the aroma of cannabis.

The company says these developments strengthen eSense's penetration into the medical cannabis markets and significant strengthens eSense's IP.

The group also says these developments expands eSense's revenue generating markets and puts it ahead of its competitors.

READ Business News Australia's Cannabis Index: a complete guide to cannabis stocks on the ASX.

eSense conducted a series of testing for antioxidant activity across its medical cannabis terpene blends including Girl Scout Cookies, OG-Kush, Sour Diesel, Jack Herer, Daniel, Super Lemon Haze, Gorilla Glue, Chees and Granddaddy Purple.

The company says a clear antioxidant activity could be seen for each one of the tested blends.

By fractioning the major terpene constituent of Jack Herer and testing each one of them for an antioxidant activity, the company says it was able to show that the antioxidant activity of each major terpene tested alone and in a mixture was significantly weaker than the antioxidant activity of the full Jack Herer blend.

eSense says this supports the notion of cannabis terpenes showing a significant antioxidant potency when acting as a whole in comparison to acting as single molecules.

eSense CEO Haim Cohen says the results are encouraging.

"We are very excited abiout this progress," says Cohen.

"eSense continually achieves new R&D heights, providing an ability to significantly strengthen our IP as well as discovering new opportunities in revenue generating markets. Without doubt our team has shown its unique ability in the medical cannabis space and we're continuing to take strides to becoming a leader in this market."

Shares in eSense-Lab are up 5.88 per cent to $0.18 per share at 11.33am AEDT.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Four ways businesses can use artificial intelligence to triumph in 2022
Partner Content
The last two years have delivered major disruption to the technology industry and broad...
PROS
Advertisement

Related Stories

Moderna booster shot receives provisional approval from TGA

Moderna booster shot receives provisional approval from TGA

The Therapeutic Goods Administration (TGA) has today provisionally ...

Circular economy company Close The Loop buys seafood packaging business for $3.25 million

Circular economy company Close The Loop buys seafood packaging business for $3.25 million

Melbourne-based circular economy company Close The Loop (ASX: CLG) ...

Former CommBank subsidiary pleads guilty to charging 499 deceased members fees

Former CommBank subsidiary pleads guilty to charging 499 deceased members fees

Investment management firm Avanteos Investments has today pleaded g...

Australian drama productions hit record $1.9 billion expenditure

Australian drama productions hit record $1.9 billion expenditure

A new report released today by Screen Australia shows a record-brea...